Published in Infect Immun on November 01, 1984
Polypeptides of Treponema pallidum: progress toward understanding their structural, functional, and immunologic roles. Treponema Pallidum Polypeptide Research Group. Microbiol Rev (1993) 2.67
Selective release of the Treponema pallidum outer membrane and associated polypeptides with Triton X-114. J Bacteriol (1988) 2.05
Antigenic and structural characterization of Treponema pallidum (Nichols strain) endoflagella. Infect Immun (1988) 1.83
The surface of virulent Treponema pallidum: resistance to antibody binding in the absence of complement and surface association of recombinant antigen 4D. Infect Immun (1986) 1.61
Cloning and expression of the major 47-kilodalton surface immunogen of Treponema pallidum in Escherichia coli. Infect Immun (1986) 1.50
Monoclonal antibody selection and analysis of a recombinant DNA-derived surface immunogen of Treponema pallidum expressed in Escherichia coli. Infect Immun (1986) 1.47
Characterization of the Treponema denticola prtP gene encoding a prolyl-phenylalanine-specific protease (dentilisin). Infect Immun (1996) 1.43
Native surface association of a recombinant 38-kilodalton Treponema pallidum antigen isolated from the Escherichia coli outer membrane. Infect Immun (1986) 1.39
Antigenic interrelationship between endoflagella of Treponema phagedenis biotype Reiter and Treponema pallidum (Nichols): molecular characterization of endoflagellar proteins. Infect Immun (1986) 1.39
Molecular characterization of the pathogen-specific, 34-kilodalton membrane immunogen of Treponema pallidum. Infect Immun (1989) 1.37
Identification and purification of a recombinant Treponema pallidum basic membrane protein antigen expressed in Escherichia coli. Infect Immun (1987) 1.35
Pathogen specificity of Treponema pallidum subsp. pallidum integral membrane proteins identified by phase partitioning with Triton X-114. Infect Immun (1988) 1.31
Chemical and biological activities of a 64-kilodalton outer sheath protein from Treponema denticola strains. J Bacteriol (1991) 1.29
Polymerase chain reaction and synthetic DNA probes: a means of distinguishing the causative agents of syphilis and yaws? Infect Immun (1990) 1.29
Purification and immunological characterization of a major low-molecular-weight lipoprotein from Borrelia burgdorferi. Infect Immun (1992) 1.27
Role of disulfide bonds in the oligomeric structure and protease resistance of recombinant and native Treponema pallidum surface antigen 4D. J Bacteriol (1987) 1.06
A new attempt to distinguish serologically the subspecies of Treponema pallidum causing syphilis and yaws. J Clin Microbiol (1990) 1.03
Isolation of a Treponema pallidum gene encoding immunodominant outer envelope protein P6, which reacts with sera from patients at different stages of syphilis. J Exp Med (1986) 0.97
Antimicrobial activity of rabbit leukocyte defensins against Treponema pallidum subsp. pallidum. Infect Immun (1991) 0.97
Primary structure of an oligomeric antigen of Treponema pallidum. Infect Immun (1989) 0.95
Opsonization of Treponema pallidum is mediated by immunoglobulin G antibodies induced only by pathogenic treponemes. Infect Immun (1993) 0.93
Cloning structural genes for Treponema pallidum immunogens and characterisation of recombinant treponemal surface protein, P2 (P2 star). Genitourin Med (1987) 0.90
Molecular cloning of Treponema pallidum outer envelope fibronectin binding proteins, P1 and P2. Genitourin Med (1987) 0.90
Isolation and characterization of recombinant Escherichia coli clones secreting a 24-kilodalton antigen of Treponema pallidum. Infect Immun (1988) 0.90
Characterization and serologic analysis of the Treponema pallidum proteome. Infect Immun (2010) 0.90
A monoclonal antibody that conveys in vitro killing and partial protection in experimental syphilis binds a phosphorylcholine surface epitope of Treponema pallidum. Infect Immun (2005) 0.86
Production and evaluation of Toxoplasma gondii recombinant GRA7 for serodiagnosis of human infections. Korean J Parasitol (2012) 0.86
Expression of antigens from chromosomal and linear plasmid DNA of Borrelia coriaceae. Infect Immun (1990) 0.86
Serospecificity of a cloned protease-resistant Treponema pallidum--specific antigen expressed in Escherichia coli. J Clin Microbiol (1986) 0.77
Treponema pallidum-immobilizing antibodies in guinea pig experimental syphilis. Infect Immun (1989) 0.76
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem (1982) 36.39
Molecular characterization of receptor binding proteins and immunogens of virulent Treponema pallidum. J Exp Med (1980) 4.19
Surface-associated host proteins on virulent Treponema pallidum. Infect Immun (1979) 4.08
Identification of Treponema pallidum antigens: comparison with a nonpathogenic treponeme. J Immunol (1982) 3.08
Humoral immune response in human syphilis to polypeptides of Treponema pallidum. J Immunol (1982) 2.99
Cultivation of virulent Treponema pallidum in tissue culture. Infect Immun (1981) 2.94
Humoral immunity in experimental syphilis. II. The relationship of neutralizing factors in immune serum to acquired resistance. J Immunol (1976) 2.91
Treponema pallidum receptor binding proteins interact with fibronectin. J Exp Med (1983) 2.90
STUDIES ON IMMUNITY IN EXPERIMENTAL SYPHILIS. I. IMMUNOLOGIC RESPONSE OF RABBITS IMMUNIZED WITH REITER PROTEIN ANTIGEN AND CHALLENGED WITH VIRULENT TREPONEMA PALLIDUM. Br J Vener Dis (1963) 2.74
Protective layer covering pathogenic treponemata. Lancet (1963) 2.60
Molecular cloning and expression of Treponema pallidum DNA in Escherichia coli K-12. Infect Immun (1983) 2.50
STUDIES ON IMMUNITY IN EXPERIMENTAL SYPHILIS. II. TREPONEMA PALLIDUM IMMOBILIZATION (TPI) ANTIBODY AND THE IMMUNE RESPONSE. Br J Vener Dis (1963) 2.44
Murine monoclonal antibodies specific for virulent Treponema pallidum (Nichols). Infect Immun (1982) 2.08
Expression of Treponema pallidum antigens in Escherichia coli. Science (1982) 2.02
Cloning and expression of Treponema pallidum (Nichols) antigen genes in Escherichia coli. Infect Immun (1983) 1.94
Molecular analysis of immunoglobulins M and G immune response to protein antigens of Treponema pallidum in human syphilis. Infect Immun (1984) 1.87
Comparison of major protein antigens and protein profiles of Treponema pallidum and Treponema pertenue. Infect Immun (1983) 1.66
Expression of Treponema pallidum antigens in Escherichia coli K-12. Infect Immun (1982) 1.59
Molecular characterization of common treponemal antigens. Infect Immun (1983) 1.44
Isolation and preliminary characterization of circulating immune complexes from rabbits with experimental syphilis. Infect Immun (1983) 1.12
Protective antibodies in the serum of syphilitic patients. Am J Hyg (1948) 1.06
Plasmid ColEl as a molecular vehicle for cloning and amplification of DNA. Proc Natl Acad Sci U S A (1974) 32.46
A critical appraisal of "chronic Lyme disease". N Engl J Med (2007) 7.84
Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science (1999) 7.75
Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem (1999) 5.81
Method for the isolation of the replication region of a bacterial replicon: construction of a mini-F'kn plasmid. J Bacteriol (1976) 5.75
Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol (2001) 5.36
Treponema pallidum (Nichols strain) in tissue cultures: cellular attachment, entry, and survival. Infect Immun (1975) 4.41
Unidirectional replication of plasmid ColE1 DNA. Nature (1974) 4.27
A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N Engl J Med (1997) 4.11
Immunogenic integral membrane proteins of Borrelia burgdorferi are lipoproteins. Infect Immun (1990) 4.10
How study design affects outcomes in comparisons of therapy. I: Medical. Stat Med (1989) 3.84
Immunity in experimental syphilis. VI. Successful vaccination of rabbits with Treponema pallidum, Nichols strain, attenuated by -irradiation. J Immunol (1973) 3.45
A new animal model for studying Lyme disease spirochetes in a mammalian host-adapted state. J Clin Invest (1998) 3.41
Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE. J Clin Microbiol (1999) 3.41
Intracellular location of Treponema pallidum (Nichols strain) in the rabbit testis. Infect Immun (1971) 3.31
Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J Immunol (2001) 3.06
Humoral immune response in human syphilis to polypeptides of Treponema pallidum. J Immunol (1982) 2.99
Characterization of the attachment of Treponema pallidum (Nichols strain) to cultured mammalian cells and the potential relationship of attachment to pathogenicity. Infect Immun (1977) 2.95
Evidence for in vivo but not in vitro expression of a Borrelia burgdorferi outer surface protein F (OspF) homologue. Mol Microbiol (1995) 2.92
Humoral immunity in experimental syphilis. II. The relationship of neutralizing factors in immune serum to acquired resistance. J Immunol (1976) 2.91
A diffusible cytotoxin of Haemophilus ducreyi. Proc Natl Acad Sci U S A (1997) 2.89
Strand and site specificity of the relaxation event for the relaxation complex of the antibiotic resistance plasmid R6K. Biochemistry (1974) 2.81
Structural similarity between the lepidoptera- and diptera-specific insecticidal endotoxin genes of Bacillus thuringiensis subsp. "kurstaki" and "israelensis". J Bacteriol (1986) 2.78
A 9.0-kilobase-pair circular plasmid of Borrelia burgdorferi encodes an exported protein: evidence for expression only during infection. Infect Immun (1994) 2.74
Purification of Treponema pallidum, Nichols strain, by Percoll density gradient centrifugation. Sex Transm Dis (1985) 2.63
Humoral immunity in experimental syphilis. I. The demonstration of resistance conferred by passive immunization. J Immunol (1976) 2.55
Sensitive detection of Treponema pallidum by using the polymerase chain reaction. J Clin Microbiol (1991) 2.51
Demonstration of rare protein in the outer membrane of Treponema pallidum subsp. pallidum by freeze-fracture analysis. J Bacteriol (1989) 2.46
Demonstration of the in vitro phagocytosis of Treponema pallidum by rabbit peritoneal macrophages. J Immunol (1978) 2.42
Treponema pallidum within cells of a primary chancre from a human female. Br J Vener Dis (1974) 2.42
Treponema pallidum invades intercellular junctions of endothelial cell monolayers. Proc Natl Acad Sci U S A (1988) 2.37
Interaction of Treponema pallidum (Nichols strain) with cultured mammalian cells: effects of oxygen, reducing agents, serum supplements, and different cell types. Infect Immun (1977) 2.33
Cross-reactivity of nonspecific treponemal antibody in serologic tests for Lyme disease. J Clin Microbiol (1990) 2.30
Changes in the surface of Leptospira interrogans serovar grippotyphosa during in vitro cultivation. Infect Immun (1991) 2.29
Molecular cloning and sequence analysis of the gene encoding OmpL1, a transmembrane outer membrane protein of pathogenic Leptospira spp. J Bacteriol (1993) 2.28
Decorin-binding protein of Borrelia burgdorferi is encoded within a two-gene operon and is protective in the murine model of Lyme borreliosis. Infect Immun (1998) 2.23
Relaxation complexes of plasmids ColE1 and ColE2: unique site of the nick in the open circular DNA of the relaxed complexes. Proc Natl Acad Sci U S A (1974) 2.22
Use of polymerase chain reaction and rabbit infectivity testing to detect Treponema pallidum in amniotic fluid, fetal and neonatal sera, and cerebrospinal fluid. J Clin Microbiol (1991) 2.20
Scanning electron microscopy of Treponema pallidum (Nichols strain) attached to cultured mammalian cells. J Bacteriol (1977) 2.19
Identification, characterization, and expression of three new members of the Borrelia burgdorferi Mlp (2.9) lipoprotein gene family. Infect Immun (1999) 2.18
Major integral membrane protein immunogens of Treponema pallidum are proteolipids. Infect Immun (1989) 2.15
Borrelia burgdorferi supercoiled plasmids encode multicopy tandem open reading frames and a lipoprotein gene family. J Bacteriol (1996) 2.14
Monoclonal antibody with hemagglutination, immobilization, and neutralization activities defines an immunodominant, 47,000 mol wt, surface-exposed immunogen of Treponema pallidum (Nichols). J Exp Med (1984) 2.11
Murine monoclonal antibodies specific for virulent Treponema pallidum (Nichols). Infect Immun (1982) 2.08
Selective release of the Treponema pallidum outer membrane and associated polypeptides with Triton X-114. J Bacteriol (1988) 2.05
Serologic analysis of first-episode nonprimary genital herpes simplex virus infection. Presence of type 2 antibody in acute serum samples. Am J Med (1984) 2.05
Expression of Treponema pallidum antigens in Escherichia coli. Science (1982) 2.02
Decorin-binding protein A (DbpA) of Borrelia burgdorferi is not protective when immunized mice are challenged via tick infestation and correlates with the lack of DbpA expression by B. burgdorferi in ticks. Infect Immun (2000) 2.00
Cardiovascular syphilis. Am J Med (1989) 1.99
Treponema pallidum (Nichols strain) in tissue cultures: cellular attachment, entry, and survival. Infect Immun (1975) 1.98
Humoral immune response in experimental syphilis to polypeptides of Treponema pallidum. J Immunol (1983) 1.97
The Sellick maneuver causing complete airway obstruction. Anesth Analg (1992) 1.96
Bidirectional replication of plasmid R6K DNA in Escherichia coli; correspondence between origin of replication and position of single-strand break in relaxed complex. Proc Natl Acad Sci U S A (1975) 1.95
Cloning and expression of Treponema pallidum (Nichols) antigen genes in Escherichia coli. Infect Immun (1983) 1.94
Performance and use of the Reiter protein complement-fixation (RPCF) test. Br J Vener Dis (1966) 1.94
Borrelia burgdorferi strain-specific Osp C-mediated immunity in mice. Infect Immun (1997) 1.93
Limited surface exposure of Borrelia burgdorferi outer surface lipoproteins. Proc Natl Acad Sci U S A (1996) 1.90
The antigenic structure of Treponema pallidum, Nichols strain. I. The demonstration, nature and location of specific and shared antigens. J Immunol (1966) 1.87
The outer membrane, not a coat of host proteins, limits antigenicity of virulent Treponema pallidum. Infect Immun (1992) 1.86
Molecular and evolutionary analysis of Borrelia burgdorferi 297 circular plasmid-encoded lipoproteins with OspE- and OspF-like leader peptides. Infect Immun (1999) 1.84
Antigenic and structural characterization of Treponema pallidum (Nichols strain) endoflagella. Infect Immun (1988) 1.83
Clinical manifestations of early syphilis by HIV status and gender: results of the syphilis and HIV study. Sex Transm Dis (2001) 1.82
A temperature-dependent rabbit model for production of dermal lesions by Haemophilus ducreyi. J Infect Dis (1991) 1.77
Complement activation limits the rate of in vitro treponemicidal activity and correlates with antibody-mediated aggregation of Treponema pallidum rare outer membrane protein. J Immunol (1990) 1.76
Immunity in experimental syphilis. V. The immunogenicity of Treponema pallidum attenuated by gamma-irradiation. J Immunol (1967) 1.73
Regulation of OspE-related, OspF-related, and Elp lipoproteins of Borrelia burgdorferi strain 297 by mammalian host-specific signals. Infect Immun (2001) 1.73
Isolation of integral membrane proteins by phase partitioning with Triton X-114. Methods Enzymol (1994) 1.70
Early reduction of immune activation in lymphoid tissue following highly active HIV therapy. AIDS (1998) 1.69
Teaching theory of mind: a new approach to social skills training for individuals with autism. J Autism Dev Disord (1995) 1.68
Plasmid DNA in Treponema pallidum (Nichols): potential for antibiotic resistance by syphilis bacteria. Science (1981) 1.67
Isolation of the outer membranes from Treponema pallidum and Treponema vincentii. J Bacteriol (1994) 1.67
The Oms66 (p66) protein is a Borrelia burgdorferi porin. Infect Immun (1997) 1.65
Virulent strain associated outer membrane proteins of Borrelia burgdorferi. J Clin Invest (1995) 1.64
Use of electroporation to construct isogenic mutants of Haemophilus ducreyi. J Bacteriol (1992) 1.61
Differentiation of convalescent animals from those vaccinated against foot-and-mouth disease by a peptide ELISA. Vaccine (1999) 1.61
The surface of virulent Treponema pallidum: resistance to antibody binding in the absence of complement and surface association of recombinant antigen 4D. Infect Immun (1986) 1.61
Reduction of nonspecific background staining in the fluorescent treponemal antibody-absorption test. J Bacteriol (1968) 1.61
A hemoglobin-binding outer membrane protein is involved in virulence expression by Haemophilus ducreyi in an animal model. Infect Immun (1996) 1.60
Evaluation of molecular methodologies and rabbit infectivity testing for the diagnosis of congenital syphilis and neonatal central nervous system invasion by Treponema pallidum. J Infect Dis (1993) 1.60
Treponema pallidum TroA is a periplasmic zinc-binding protein with a helical backbone. Nat Struct Biol (1999) 1.60
Molecular characterization of a 6.6-kilodalton Borrelia burgdorferi outer membrane-associated lipoprotein (lp6.6) which appears to be downregulated during mammalian infection. Infect Immun (1997) 1.57
The TprK protein of Treponema pallidum is periplasmic and is not a target of opsonic antibody or protective immunity. J Exp Med (2001) 1.57